Onward Medical N.V. (ONWD) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.679x

Based on the latest financial reports, Onward Medical N.V. (ONWD) has a cash flow conversion efficiency ratio of -0.679x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-18.81 Million ≈ $-22.00 Million USD) by net assets (€27.72 Million ≈ $32.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Onward Medical N.V. - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how Onward Medical N.V.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Onward Medical N.V. (ONWD) financial obligations for a breakdown of total debt and financial obligations.

Onward Medical N.V. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Onward Medical N.V. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Malayan Flour Mills Bhd KLSE:3662	0.098x
Kaap Agri Bedryf Employee and Farm Worker Bee Trust JSE:KAL	0.235x
Seoul City Gas KO:017390	-0.022x
GOCL Corporation Limited NSE:GOCLCORP	-0.008x
Adi Sarana Armada Tbk JK:ASSA	0.091x
Korea Information Certificate Authority Inc KQ:053300	0.019x
Kyeryong Const KO:013580	-0.111x
Legal & General Group PLC LSE:LGEN	2.275x

Annual Cash Flow Conversion Efficiency for Onward Medical N.V. (2018–2024)

The table below shows the annual cash flow conversion efficiency of Onward Medical N.V. from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see Onward Medical N.V. (ONWD) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€48.05 Million ≈ $56.18 Million	€-31.76 Million ≈ $-37.13 Million	-0.661x	+63.27%
2023-12-31	€17.93 Million ≈ $20.96 Million	€-32.27 Million ≈ $-37.73 Million	-1.800x	-254.95%
2022-12-31	€52.63 Million ≈ $61.53 Million	€-26.68 Million ≈ $-31.20 Million	-0.507x	-110.94%
2021-12-31	€82.68 Million ≈ $96.67 Million	€-19.87 Million ≈ $-23.23 Million	-0.240x	-159.80%
2020-12-31	€-32.09 Million ≈ $-37.52 Million	€-12.90 Million ≈ $-15.08 Million	0.402x	-39.07%
2019-12-31	€-14.92 Million ≈ $-17.45 Million	€-9.85 Million ≈ $-11.51 Million	0.660x	-5.33%
2018-12-31	€-10.27 Million ≈ $-12.01 Million	€-7.16 Million ≈ $-8.37 Million	0.697x	--

About Onward Medical N.V.

BR:ONWD Belgium Biotechnology

Market Cap

$174.18 Million

€148.98 Million EUR

Market Cap Rank

#17050 Global

#71 in Belgium

Share Price

€2.66

Change (1 day)

+0.38%

52-Week Range

€2.65 - €5.52

All Time High

€12.90